Published in Nature on June 04, 2015
Applications of CRISPR technologies in research and beyond. Nat Biotechnol (2016) 1.34
Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery. Nat Methods (2015) 0.96
Engineering large animal models of human disease. J Pathol (2015) 0.94
DNA-binding-domain fusions enhance the targeting range and precision of Cas9. Nat Methods (2015) 0.88
Advancements in zebrafish applications for 21st century toxicology. Pharmacol Ther (2016) 0.82
Synthetic dual-input mammalian genetic circuits enable tunable and stringent transcription control by chemical and light. Nucleic Acids Res (2015) 0.81
CRISPR-Cas9: A European position on genome editing. Nature (2017) 0.81
Regulating the New: A Consideration of CRISPR and Approaches to Professional Standards of Practitioners of Chinese Medicine in Australia and Accessing the NDIS. J Bioeth Inq (2017) 0.80
Diversity of CRISPR-Cas immune systems and molecular machines. Genome Biol (2015) 0.78
Unwanted mutations: Standards needed for gene-editing errors. Nature (2015) 0.78
A decade of discovery: CRISPR functions and applications. Nat Microbiol (2017) 0.77
Somatic Engineering of Oncogenic Chromosomal Rearrangements: A Perspective. Cancer Res (2016) 0.77
Recent advances in understanding apicomplexan parasites. F1000Res (2016) 0.77
Comparison of CRISPR/Cas9 and TALENs on editing an integrated EGFP gene in the genome of HEK293FT cells. Springerplus (2016) 0.77
Single-Base Pair Genome Editing in Human Cells by Using Site-Specific Endonucleases. Int J Mol Sci (2015) 0.77
Bedside Back to Bench: Building Bridges between Basic and Clinical Genomic Research. Cell (2017) 0.76
Preclinical models for interrogating drug action in human cancers using Stable Isotope Resolved Metabolomics (SIRM). Metabolomics (2016) 0.75
From hacking the human genome to editing organs. Organogenesis (2015) 0.75
The anti-melanoma activity and oncogenic targets of hsa-miR-15a-5p. RNA Dis (2016) 0.75
The Challenges and Opportunities Associated with Biofortification of Pearl Millet (Pennisetum glaucum) with Elevated Levels of Grain Iron and Zinc. Front Plant Sci (2016) 0.75
The evolutionary ecology of molecular replicators. R Soc Open Sci (2016) 0.75
Oligonucleotides targeting coagulation factor mRNAs: use in thrombosis and hemophilia research and therapy. Thromb J (2017) 0.75
GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases. BMC Genomics (2017) 0.75
Technological advances in precision medicine and drug development. Expert Rev Precis Med Drug Dev (2016) 0.75
Genome-wide profiling of genetic variation in Agrobacterium-transformed rice plants. J Zhejiang Univ Sci B (2016) 0.75
"I bet you won't": The science-society wager on gene editing techniques. EMBO Rep (2016) 0.75
Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology. J Neurophysiol (2016) 0.75
Mitochondrial Modification Techniques and Ethical Issues. J Clin Med (2017) 0.75
Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework. Am J Bioeth (2015) 0.75
Programmable Genome Editing Tools and their Regulation for Efficient Genome Engineering. Comput Struct Biotechnol J (2017) 0.75
A need for a systematic genetic evaluation of hereditary polyuric patients. Clin Kidney J (2016) 0.75
Prevention of Preharvest Sprouting through Hormone Engineering and Germination Recovery by Chemical Biology. Front Plant Sci (2017) 0.75
Emerging ethical perspectives in the clustered regularly interspaced short palindromic repeats genome-editing debate. Per Med (2016) 0.75
Let microorganisms do the talking, let us talk more about microorganisms. Fungal Biol Biotechnol (2016) 0.75
Strategies to Improve Saccharomyces cerevisiae: Technological Advancements and Evolutionary Engineering. Indian J Microbiol (2017) 0.75
Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein". Mol Genet Genomics (2017) 0.75
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
CRISPR provides acquired resistance against viruses in prokaryotes. Science (2007) 29.74
RNA-programmed genome editing in human cells. Elife (2013) 14.82
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell (2015) 7.80
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol (2014) 5.71
Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol (1987) 5.28
Biotechnology. Regulating gene drives. Science (2014) 4.25
Long stretches of short tandem repeats are present in the largest replicons of the Archaea Haloferax mediterranei and Haloferax volcanii and could be involved in replicon partitioning. Mol Microbiol (1995) 3.92
Genome editing. The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations. Science (2015) 3.56
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature (2014) 3.15
A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families. Sci Adv (2015) 1.37
US regulation misses some GM crops. Nature (2013) 1.06
The Chlamydomonas genome reveals the evolution of key animal and plant functions. Science (2007) 11.15
Education: The PhD factory. Nature (2011) 6.97
Universities struggle to make patents pay. Nature (2013) 2.52
Human-subjects research: trial and error. Nature (2007) 2.23
Indirect costs: keeping the lights on. Nature (2014) 2.06
Cruel fusion: What a young man's death means for childhood cancer. Nature (2017) 2.04
Researcher refuses to back down over race case. Nature (2007) 2.02
Call to censor flu studies draws fire. Nature (2012) 1.99
Cancer theory faces doubts. Nature (2011) 1.95
Research ethics: 3 ways to blow the whistle. Nature (2013) 1.89
Translational research: the full cycle. Nature (2008) 1.58
Language: Disputed definitions. Nature (2008) 1.53
Transgenic salmon nears approval. Nature (2013) 1.51
Garage biotech: Life hackers. Nature (2010) 1.49
Myriad ruling causes confusion. Nature (2013) 1.48
US plant scientists seek united front. Nature (2011) 1.42
Chimps' fate ignites debate. Nature (2010) 1.40
US personalized-medicine industry takes hit from Supreme Court. Nature (2016) 1.38
Big science: The cancer genome challenge. Nature (2010) 1.38
Blockbuster drug bows out. Nature (2011) 1.34
Drug giants turn their backs on RNA interference. Nature (2010) 1.34
Botanical identities. Nature (2008) 1.33
Cystic fibrosis drug Vertex's latest triumph. Nat Biotechnol (2012) 1.28
Translational research: 4 ways to fix the clinical trial. Nature (2011) 1.20
How to solve the world's biggest problems. Nature (2015) 1.18
From the frontline: 30 something science. Nature (2013) 1.17
HIV vaccine may raise risk. Nature (2007) 1.16
Medicine Nobel for research on how cells 'eat themselves'. Nature (2016) 1.08
Complex synthesis yields breast-cancer therapy. Nature (2010) 1.08
Insider trading sparks concerns. Nature (2013) 1.08
Biomedicine wins big in US budget deal. Nature (2015) 1.07
Bitter fight over CRISPR patent heats up. Nature (2016) 1.07
US regulation misses some GM crops. Nature (2013) 1.06
Collaborations: with all good intentions. Nature (2008) 1.00
The death of microarrays? Nature (2008) 1.00
Monoclonal antibodies come of age. Nature (2008) 0.99
Boom in unproven cell therapies intensifies regulatory debate. Nature (2016) 0.97
Cancer treatment: The killer within. Nature (2014) 0.97
Melanoma drug wins US approval. Nature (2011) 0.97
Drug safety crackdown revs up. Nature (2010) 0.96
Stem cells for Snoopy: pet medicines spark a biotech boom. Nature (2016) 0.96
Depression drug disappoints. Nature (2011) 0.96
Funding agencies toughen stance on open access. Nature (2006) 0.96
Cancer-fighting viruses win approval. Nature (2015) 0.96
'Master protocol' aims to revamp cancer trials. Nature (2013) 0.95
CRISPR: gene editing is just the beginning. Nature (2016) 0.94
Biohackers gear up for genome editing. Nature (2015) 0.94
Clinical drug tests adapted for speed. Nature (2010) 0.93
Drug markers questioned. Nature (2008) 0.93
Rare victory in fight against melanoma. Nature (2010) 0.91
Work ethic: The 24/7 lab. Nature (2011) 0.90
Drug candidates derailed in case of mistaken identity. Nature (2012) 0.90
Ageing: Much ado about ageing. Nature (2010) 0.89
Metabolic quirks yield tumour hope. Nature (2014) 0.88
Stem-cell scientists grapple with clinics. Nature (2011) 0.87
Diabetes drugs ride a bumpy road. Nature (2013) 0.87
Drug buddies. Nature (2011) 0.87
Drug bests cystic-fibrosis mutation. Nature (2012) 0.86
Brazilian courts tussle over unproven cancer treatment. Nature (2015) 0.86
A synthetic-biology reality check. Nature (2009) 0.86
Cancer: The Ras renaissance. Nature (2015) 0.85
New year, new science. Nature (2011) 0.85
Immunotherapy's cancer remit widens. Nature (2013) 0.85
Biotechs go generic: the same but different. Nature (2007) 0.85
'Biosimilar' drugs poised to penetrate market. Nature (2010) 0.85
End of cancer-genome project prompts rethink. Nature (2015) 0.84
Key Alzheimer's findings questioned. Nature (2010) 0.84
Fly library boosts gene tool supply. Nature (2007) 0.84
Biotech boom prompts fears of bust. Nature (2013) 0.84
Malaria may not rise as world warms. Nature (2010) 0.83
Plant biologists fear for cress project. Nature (2010) 0.83
Stem-cell success aids diabetes fight. Nature (2014) 0.83
Forest growth studies begin to turn up the heat. Nature (2009) 0.83
US fiscal deal leaves science vulnerable. Nature (2013) 0.82
Life-changing experiments: The biological Higgs. Nature (2012) 0.82
Psychiatry manual revisions spark row. Nature (2009) 0.82
Transgenic grass skirts regulators. Nature (2011) 0.82
Targeted gene editing enters clinic. Nature (2011) 0.81
Microbes reveal extent of biodiversity. Nature (2007) 0.81
Salmon approval heralds rethink of transgenic animals. Nature (2015) 0.81
US cancer institute to overhaul tumour cell lines. Nature (2016) 0.81
A shot in the arm for cancer vaccines? Nature (2010) 0.81
Cholesterol limits lose their lustre. Nature (2013) 0.81
Halfway point for 1,001 genomes quest. Nature (2011) 0.80
AstraZeneca launches project to sequence 2 million genomes. Nature (2016) 0.79
Bioengineers look beyond patents. Nature (2013) 0.79
Sizing up a slow assault on cancer. Nature (2013) 0.79
Seed-patent case in Supreme Court. Nature (2013) 0.79
The unsung heroes of CRISPR. Nature (2016) 0.78
Mice share yeast's ageing system. Nature (2008) 0.78
When there's no room to grow. Nature (2008) 0.78
Success against blindness encourages gene therapy researchers. Nature (2015) 0.78
Disease research: Rare insights. Nature (2014) 0.78
Cyberinfrastructure: Feed me data. Nature (2009) 0.78
Mini enzyme moves gene editing closer to the clinic. Nature (2015) 0.78
The printed organs coming to a body near you. Nature (2015) 0.78
Slim spoils for obesity drugs. Nature (2010) 0.78
Therapeutic cancer vaccine survives biotech bust. Nature (2015) 0.78
Biotechnology: Virtual reality. Nature (2013) 0.78
Bankruptcy filing worries developers of nanoparticle cancer drugs. Nature (2016) 0.78